Latest News about RGEN
Recent news which mentions RGEN
Stocks That Hit 52-Week Lows On Tuesday
April 19, 2022
From Benzinga
From MarketWatch
From InvestorPlace
2 Top Biotech Stocks to Buy for the Long Haul
April 07, 2022
From Motley Fool
Repligen Earnings Perspective: Return On Capital Employed
February 18, 2022
Tickers
RGEN
From Benzinga
10 Biggest Price Target Changes For Friday
February 18, 2022
From Benzinga
Repligen's Q4 Earnings Beat Expectations, Issues Solid FY22 Guidance
February 17, 2022
Tickers
RGEN
From Benzinga
The Daily Biotech Pulse: J&J Unit Announces Research Collaboration With Remix, Regencell Touts COVID Data, Decision Day For Agios
February 17, 2022
From Benzinga
Earnings Scheduled For February 17, 2022
February 17, 2022
From Benzinga
The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More
February 13, 2022
From Benzinga
2 Healthcare Stocks That Could Help Set You Up for Life
January 20, 2022
From Motley Fool
These Are 5 of the Fastest-Growing Large-Cap Stocks on the Planet
January 13, 2022
From Motley Fool
Repligen Corp (RGEN) Q3 2021 Earnings Call Transcript
October 28, 2021
Tickers
RGEN
From Motley Fool
From Benzinga
Earnings Scheduled For October 28, 2021
October 28, 2021
From Benzinga
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
October 24, 2021
From Benzinga
NIO Stock Is Very Richly Valued, But I Can See Why It Tempts People
October 19, 2021
From InvestorPlace
2 Tricks and a Treat for Gene Therapy Investors
October 18, 2021
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2021
October 14, 2021
From Benzinga
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
September 30, 2021
From Benzinga
The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data
September 23, 2021
From Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs
September 22, 2021
From Benzinga
3 Unstoppable Healthcare Stocks to Buy With Just $1,000
September 22, 2021
From Motley Fool
Great Performers That Are Still Great Stocks
September 21, 2021
From Motley Fool
The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data
September 21, 2021
From Benzinga
10 Biggest Price Target Changes For Friday
September 17, 2021
From Benzinga
The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold
September 17, 2021
From Benzinga
Repligen Reinforces Proteins Business With $150M Avitide Acquisition Deal
September 16, 2021
Tickers
RGEN
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.